Gene · 389
Papers2,557
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
441 to 460 of 2,557
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Rho GTPase signaling in rheumatic diseases. | iScience | 2022 | 35005558 | PubTator, text mining | PubMed |
| Role of RHO family interacting cell polarization regulators (RIPORs) in health and disease: Recent advances and prospects. | Int J Biol Sci | 2022 | 35002526 | PubTator, text mining | PubMed |
| StarD13 negatively regulates invadopodia formation and invasion in high-grade serous (HGS) ovarian adenocarcinoma cells by inhibiting Cdc42. | Eur J Cell Biol | 2022 | 34958986 | PubTator, text mining | PubMed |
| An In Vivo CRISPR Screen Identifies Stepwise Genetic Dependencies of Metastatic Progression. | Cancer Res | 2022 | 34916221 | PubTator, text mining | PubMed |
| RNF168 suppresses the cancer stem cell-like traits of nonsmall cell lung cancer cells by mediating RhoC ubiquitination. | Environ Toxicol | 2022 | 34873829 | PubTator, text mining | PubMed |
| Understanding and targeting prostate cancer cell heterogeneity and plasticity. | Semin Cancer Biol | 2022 | 34844845 | PubTator, text mining | PubMed |
| Genomic comparisons between hepatocarcinogenic and non-hepatocarcinogenic organophosphate insecticides in the mouse liver. | Toxicology | 2022 | 34813904 | PubTator, text mining | PubMed |
| Molecular implications of HOX genes targeting multiple signaling pathways in cancer. | Cell Biol Toxicol | 2022 | 34617205 | PubTator, text mining | PubMed |
| MicroRNAs and their role in the malignant transformation of oral leukoplakia: a scoping review. | Med Oral Patol Oral Cir Bucal | 2022 | 34564679 | PubTator, text mining | PubMed |
| The Integrated "Multiomics" Landscape at Peak Injury and Resolution From Alcohol-Associated Liver Disease. | Hepatol Commun | 2022 | 34558855 | PubTator, text mining | PubMed |
| Discovery of Cellular RhoA Functions by the Integrated Application of Gene Set Enrichment Analysis. | Biomol Ther (Seoul) | 2022 | 34429388 | PubTator, text mining | PubMed |
| Regulation of Leukaemia Associated Rho GEF (LARG/ARHGEF12). | Small GTPases | 2022 | 34304710 | PubTator, text mining | PubMed |
| Extracellular Vesicles as an Emerging Treatment Option for Intervertebral Disc Degeneration: Therapeutic Potential, Translational Pathways, and Regulatory Considerations. | Adv Healthc Mater | 2022 | 34297485 | PubTator, text mining | PubMed |
| The role of RNA editing enzyme ADAR1 in human disease. | Wiley Interdiscip Rev RNA | 2022 | 34105255 | PubTator, text mining | PubMed |
| Novel adapter CAR-T cell technology for precisely controllable multiplex cancer targeting. | Oncoimmunology | 2021 | 35686214 | PubTator, text mining | PubMed |
| Statins and endocrine resistance in breast cancer. | Cancer Drug Resist | 2021 | 35582035 | PubTator, text mining | PubMed |
| Exosomes Immunity Strategy: A Novel Approach for Ameliorating Intervertebral Disc Degeneration. | Front Cell Dev Biol | 2021 | 35223870 | PubTator, text mining | PubMed |
| FAM65A as a novel prognostic biomarker in human tumors reveal by a pan-cancer analysis. | Discov Oncol | 2021 | 35201499 | PubTator, text mining | PubMed |
| Role of ARHGEF3 as a GEF and mTORC2 Regulator. | Front Cell Dev Biol | 2021 | 35174167 | PubTator, text mining | PubMed |
| MicroRNAs in head and neck squamous cell carcinoma: a possible challenge as biomarkers, determinants for the choice of therapy and targets for personalized molecular therapies. | Transl Cancer Res | 2021 | 35116619 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/389/papers?page=23